Top Markets
#1 Palladium Network Palladium Network +27.90%
#2 Ankr Network Ankr Network +20.08%
#3 Fake World Assets Fake World Assets +8.58%
#4 Status Status +8.22%
#5 Pons Pons +6.97%
#6 Ribbita by Virtuals Ribbita by Virtuals +6.85%
#7 would would +6.62%
#8 WAX WAX +6.52%
#9 edgeX edgeX +6.10%
#10 Hive Hive +4.94%
Coin of the day
Palladium Network Palladium Network
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Nevro Corp. Nevro Corp.

Nevro Corp.

NVRO
Rang in aandelen #17833
Nevro Corp. is a medical technology firm that delivers solutions for... Nevro Corp. is a medical technology firm that delivers solutions for individuals experiencing persistent pain, serving markets both domestically in the United States and across the globe. The company's core business involves the development and market introduction of the Senza spinal cord stimulation (SCS) system, an advanced, clinically supported neuromodulation platform specifically engineered to alleviate chronic pain. This portfolio encompasses its newer generations, the Senza II and Senza Omnia systems. Additionally, Nevro offers its proprietary 10 kHz Therapy, providing neuromodulation approaches grounded in robust clinical evidence for effective chronic pain management. Its products are distributed through a diverse strategy, utilizing a dedicated direct sales team complemented by a network of specialized sales agents and independent distributors. Founded in 2006, Nevro Corp. maintains its corporate headquarters in Redwood City, California.
Aandeelprijs
$5.84
Laatst gesynchroniseerd: 2025-04-02
Marktkapitalisatie
$224.09M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel Nevro Corp. (NVRO)

Categorie

Healthcare
Winst voor Nevro Corp. (NVRO)
Winst in Dec 2024 TTM: $-112.35M
Volgens de meest recente financiële verslagen van Nevro Corp. bedraagt de huidige winst van het bedrijf $-112.35M. In 2023 behaalde het bedrijf een winst van $-97.86M, een daling ten opzichte van de winst van 2022, die $4.26M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Nevro Corp. van 2012 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
2026 (TTM) $-112.35M 0.00%
2024 $-112.35M 14.80%
2023 $-97.86M -2,395.00%
2022 $4.26M -103.26%
2021 $-130.83M 59.16%
2020 $-82.20M -19.48%
2019 $-102.09M 110.76%
2018 $-48.44M 37.41%
2017 $-35.25M 16.90%
2016 $-30.16M -54.49%
2015 $-66.27M 119.41%
2014 $-30.20M 17.74%
2013 $-25.65M 36.41%
2012 $-18.81M 0.00%
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
$7.51B -6,785.60%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
$5.15B -4,682.27%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
$5.56B -5,051.67%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
$3.86B -3,536.70%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
$1.42B -1,361.82%
US